Lipocine (LPCN) Change in Taxes (2012 - 2016)

Lipocine's (LPCN) quarterly Change in Taxes came in at $700.0 in Q1 2016, up 101.26% on a QoQ basis from -$55342.0 in Q3 2013.

Lipocine (LPCN) Change in Taxes (2012 - 2016) Analysis & Trends

Lipocine (LPCN) has 3 years of Change in Taxes data on file, last reported at $700.0 in Q1 2016.

Quarterly Change in Taxes changed N/A year-over-year to $700.0 in Q1 2016, while the trailing twelve-month figure through Mar 2017 was $700.0 (changed 0.0% YoY) and the FY2013 annual result came in at -$55048.0, down 8147.95% from the prior year.
Change in Taxes improved to $700.0 in Q1 2016, from -$55342.0 in the prior quarter.
In the past five years, Change in Taxes ranged from a high of $700.0 in Q1 2016 to a low of -$55342.0 in Q3 2013.
A 3-year average of -$10767.0 and a median of $182.0 in 2013 frame the typical range for Change in Taxes.
The widest YoY moves for Change in Taxes: up 10887.91% in 2013, down 10887.91% in 2013.
Tracing LPCN's Change in Taxes over 3 years: stood at $513.0 in 2012, then sank by 10887.91% to -$55342.0 in 2013, then soared by 101.26% to $700.0 in 2016.
The last three Change in Taxes figures came in at $700.0 (Q1 2016), -$55342.0 (Q3 2013), and $182.0 (Q2 2013), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Taxes (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	-
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	90.33 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Lipocine	11.15 Mn	-12.76 Mn	-	-

Download Data